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Objectives. The current study assessed the role of hypervigilance for bodily sensations 
in the back in long term low back pain (LBP) problems. Methods. People with chronic 
low back pain (CLBP), recurrent low back pain (RLBP), and no LBP were compared on 
the extent to which they attended to somatosensory stimuli on the back during a 
movement task. To measure hypervigilance, somatosensory event-related potentials 
(SEP) to task-irrelevant tactile stimuli on the back were measured when preparing 
movements in either a threatening or a neutral condition, indicated by a cue signaling 
possible pain on the back during movement or not. Results. Results showed stronger 
attending to stimuli on the back in the threat condition than in the neutral condition, as 
reflected by increased amplitude of the N96 SEP. However, this effect did not differ 
between groups. Similarly, for all three groups the amplitude of the P172 was larger for 
the threatening condition, suggesting a more general state of arousal resulting in increased 
somatosensory responsiveness. No significant associations were found between 
somatosensory attending to the back and theorized antecedents such as pain 
catastrophizing, pain-related fear and pain vigilance. Discussion. The current study 
confirmed that individuals preparing a movement attended more towards somatosensory 
stimuli at the lower back when anticipating back pain during the movement, as measured 
by the N96 SEP. However, no differences were found between participants suffering from 









The fear-avoidance model states that long term back pain problems might develop 
as a result of persistent fear-induced 'safety-seeking behaviors', including activity 
avoidance and ‘hypervigilance’ (i.e., heightened attending) to pain-related information 
and bodily sensations. While the evidence for the role of avoidance behavior is abundant2, 
the status of hypervigilance is less clear. Research has focused almost exclusively on 
attending to semantic representations of pain. Although meta-analyses suggest increased 
attending to (sensory) pain words in chronic pain patients compared to healthy controls, 
these effects were small3 and no consistent associations with theorized antecedents (e.g., 
fear) were found4. 
It has been argued that semantic pain stimuli, such as pictures showing painful 
situations or words related to the experience of pain, might be insufficient to evoke bodily 
threat, and it has been recommended to focus on attentional processing of somatosensory 
stimuli4,5. There has been increasing effort to develop somatosensory attention 
paradigms6,7, but research was mainly limited to pain-free populations. One notable 
exception is a study by Peters and colleagues8, who instructed chronic low back pain 
(CLBP) patients to detect electrical stimuli of slowly increasing intensity on the back 
while performing an auditory task. No evidence for hypervigilance was found, as CLBP 
patients were not faster than pain-free controls in detecting stimuli on the back. However, 
a potential problem is that both groups may have strongly focused on the somatosensory 
stimuli because of the task instructions, whereas attending to pain is rather a spontaneous 
reaction. It is therefore unclear how attention to pain is guided without any instruction to 
do so.  
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In an attempt to solve this problem Clauwaert and colleagues9,10 used 
electroencephalography (EEG) to assess somatosensory event-related potentials (SEPs) 
to task-irrelevant tactile stimuli on the hands9 or the lower back10 while preparing pain-
conditioned and neutral movements that recruited the simulated body part. In both studies, 
they identified similar increased SEPs indicative for somatosensory attending (i.e. the 
N120 when stimulating at the hand and N95 when stimulating at the lower back) when 
stimuli were presented on the body part that was recruited to perform the pain-conditioned 
movement.  
The current study used a similar paradigm as Clauwaert and colleagues10 for 
application to low back pain (LBP). SEPs to tactile stimuli on the back were recorded 
while participants prepared rapid arm movements in either threatening or neutral 
conditions, indicated by a cue signaling whether the movement could be accompanied by 
a painful stimulus on the back or not. We compared a control group without LBP to 
persons with CLBP and recurrent low back pain (RLBP), thereby taking the degree of 
chronicity of LBP into account. 
We hypothesized that somatosensory attending to the back, as indicated the 
N120/N95 SEPs amplitudes in particular, would be increased in the threat than in the 
neutral condition, and that effects would be larger in the LBP groups than in the control 
group. Given the difference in chronicity, we expected larger effects in the CLBP than in 
the RLBP group. Finally, we explored associations between somatosensory attending to 









An a priori sample size calculation showed that a minimum of 66 participants was 
necessary to detect a medium effect size (Cohen’s f= 0.25) at α = 0.05 and 95% power. 
We exceeded this amount in order to increase the chance to detect small-to-medium 
effects. One hundred and nine individuals with CLBP (N=32), RLBP (N=33), and without 
LBP (N=44) were recruited via social media, flyers distributed in public areas, several 
Belgian hospitals, and private practices of physicians or physiotherapists. All included 
LBP patients had to suffer from non-specific LBP, which was defined as pain in the 
lumbar region that is not attributable to a recognizable, known specific pathology (e.g. 
histories of spinal traumata or deformities, severe degenerative changes or scoliosis, 
osteoporosis, obesity, radicular signs, malignancies, metabolic or rheumatologic diseases, 
spinal surgery, neuropathic pain, etc.11. The LBP had to be initiated ≥6 months ago and 
was of such a severity that it lasted for at least 24 hours, interfered with daily activities 
and a clinician (medical doctor or physiotherapist) had been consulted 12,13.  
Individuals were classified as RLBP when they experienced ≥2 reoccurring LBP 
flares per year during which the mean LBP intensity was ≥2 on a visual analogue scale 
(VAS)13,14. The painful episodes were alternated with pain-free episodes of LBP 
remission lasting ≥1 month 13,15. The RLBP patients included in this study were examined 
while in a state of remission. This way, potential differences between the RLBP and 
control group could not be confounded by current presence of pain, and thus should reflect 
cognitive processes. Individuals were classified as CLBP when the pain complaints were 
present weekly, occurring at least on 3 out of 7 days 16,17.  
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For the control group participants were allowed if they did not suffer from any 
pain disorders (in the past) nor pain complaints at the moment the experiments took place, 
and who never experienced LBP complaints >24 hours of that severity that they consulted 
a (para)medic.  
Individuals with (a history) of severe respiratory, orthopedic, neurological, 
systematic, metabolic or circulatory conditions, or with a history of spinal surgery, spinal 
trauma or severe spinal deformities were not eligible for study inclusion. Additionally, 
pregnant women were not allowed to participate. Furthermore, only Dutch speaking 
participants between the ages of 18 and 45, with a healthy body mass index (BMI ≤25) 
were eligible. Importantly, the 3 groups were matched on gender and age. Both right- and 
left-hand dominant participants were included. 
Participants were asked to refrain from consuming caffeine, alcohol, nicotine and 
physical exertion 48 hours before or on the day of the experiments. Moreover, participants 
were asked not to take in painkillers, muscle-specific or general relaxant medication to 
eliminate strong acute effects, and to maintain a normal sleep pattern the night before 
testing.  
Before the start of the testing, participants received an information brochure about 
the study. Participants were also told that they were free to not participate or to terminate 
the experiment at any time should they so desire. All participants agreed to continue with 
the experiment and signed an informed consent. The participants took part in the 
experiment in exchange for a monetary reward and were not informed about the specific 
goals of this study before the start of the experiment. However, at the end of the 
experiment all participants received an elaborate debriefing. This study was approved by 
the committee of medical ethics of Ghent University (study 2016/0168), where the 
7 
 
experiment took place, and was performed according to the ethical standards laid down 




2.2.1 Tactile stimulus. A resonant-type tactor (C-2 TACTOR, Engineering 
Acoustics, Inc., Florida) was used to administer vibrotactile (VT) stimuli (200 ms) to the 
low back, centrally at the L3 spinous process level. The amplitude and frequency were 
controlled by a self-developed software program. The tactor was attached directly to the 
skin surface by means of a double-sided tape ring and was driven by a custom-built device 
at 200 Hz. To prevent any interference from environmental noise, participants were asked 
to wear earplugs. The intensity of the VT stimulus was the same for all participants and 
did not vary across the experiment.  
2.2.2 Electrocutaneous stimulus. The painful electrocutaneous stimulus (ES, 
bipolar; 50Hz; 200 ms; instantaneous rise and fall time) was delivered by means of a 
Constant Current Stimulator (DS5, Digitimer Ltd, Hertfordshire, UK) with two lubricated 
Medcat surface electrodes (1cm diameter). These electrodes were placed directly 
underneath the tactor at the L4 spinous process. Participants were first presented with an 
ES of low amplitude (0.5 mA) to prevent the initial surprise from influencing the 
evaluation of the stimulus. After this, the participants were presented with the same 
stimulus and were motivated to choose an intensity that they evaluated as unpleasant as 
possible but that they were still willing to receive during the experiment. After every 
stimulation, the participant was asked to indicate whether the researcher was allowed to 
increase the intensity or not. If the participant agreed, the amplitude was elevated in steps 
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of 0.5 mA until the participant indicated to have reached the maximum intensity 
(procedure in line with 9,18). Once a higher amplitude was chosen, the participants could 
not go back to a lower amplitude. Since movement can suppress the perception of sensory 
information (i.e. sensory suppression)19,20, the participants also received their individually 
chosen maximum intensity while performing a rapid arm movement and were asked again 
whether they agreed to increase the intensity or not. If they agreed, the intensity was 
increased in steps of 0.5 mA until they reached their maximum intensity during movement 
execution.  
2.2.3 Sensor-box. To register the start of the movement execution, a custom-built 
optical sensor-box was used. This sensor-box was attached to the participant’s hip at the 
side of the dominant arm, at a height which the participants could easily reach with 
fingertip.  
2.2.4 EEG. Brain activity was recorded continuously using the eego sports (ANT 
neuro system) recording system at a sampling rate of 2,000 Hz from 32 active electrodes, 
placed according to the international 10/20 setting. The ground electrode was located in 
the active-shield cap fronto-centrally between the FPz and the Fz electrode and all 
channels were referenced online to the average of all signals. Impedances were kept 
below 10 kΩ. Data were further preprocessed off-line by using Brainvision Analyzer 2.1 
(Brain Products GmbH, Munich, Germany). 
2.2.5 Experiment software. The experiment was programmed in C-language 
using the Tscope 5 library package21. Triggers were controlled by the experimental 





2.3 Design  
 
This study was part of a larger project in which participants were invited for two 
different testing sessions: a session in which the effect of threat of experimentally induced 
back pain was examined (pain session), and a session without any administration of 
experimental pain (no-pain session). The pain session included both painful and pain-free 
trials, whereas the no-pain session included only pain-free trials. There were at least 5 
days between the two sessions, and the order of these sessions was randomized across 
participants. Note that only the procedure and the data of the pain session will be reported 
in the current paper, since the no-pain session had different research goals and used a 
somewhat different paradigm. However, because the same movements had to be 
performed in both sessions, any order effects will be controlled for. 
 
2.4 Experimental procedure 
 
Participants were asked to stand straight in front of a computer, with the feet at 
shoulder width and the arms hanging relaxed alongside their body. A screen was 
positioned at the eye level of the participant 2m in front of them. First, the intensity of the 
ES was calibrated for each participant. Next, the participants learned to execute the arm 
movement correctly as instructed by one of the experimenters. This movement consisted 
of moving the dominant arm22,23,24 away from a sensor box attached at the hip, by 
performing either a forward arm movement with a stretched arm towards 90° of shoulder 
flexion, or backwards in an angle of 30° of shoulder extension, and back to the sensor-
box as quickly as possible22. These rapid arm movements (RAM) were chosen because 
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they disturb the trunk posture, eliciting an anticipatory postural response of the lower 
back muscles to restore balance. Moreover, this task has been previously used to this end 
in healthy people as well as those with LBP25,26. This specific motor task was selected to 
allow the recording of electromyography (EMG) during movement execution, which was 
not the focus of this study but part of the larger project. EMG data were not reported in 
the present manuscript. In the movement practice phase, participants practiced the 
movement under supervision of the experimenters and received feedback about their 
performance for a total of 6 trials (3 in each direction). Meanwhile, one of the 
experimenters evaluated the accuracy and speed of the movement, as well as whether a 
stretched arm during movement execution was maintained. If needed, the practice phase 
was repeated until the movement was executed as requested.  
Following the movement training, the experiment started with a practice block of 
24 trials, which was not included in the analyses. In this block, the participants learned 
the association between the color of a cue presented on the screen (i.e. a blue or pink ball) 
and the possible administration of either an unpleasant ES stimulus or a non-painful VT 
stimulus during movement execution. The association between the color of the ball and 
the type of stimulus was randomized across participants. Moreover, participants were 
verbally informed of this association by the experimenter before the start of the 
experiment, to facilitate learning27. Each trial started with the presentation of a fixation 
cross (500ms), followed by a blue or pink ball. The duration of this cue was 3000ms. 
During this interval, a VT with a duration of 200ms was presented at the lower back to 
induce the somatosensory evoked potentials. The moment of stimulation onset varied 
between 2000 and 2500ms after the presentation of the cue. After this cue had 
disappeared, a second cue was presented, indicating which movement had to be 
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performed. When a white upwards-pointing arrow was presented, the participants were 
instructed to execute a forward arm movement as quickly as possible. When the arrow 
pointed downwards, the participants were instructed to perform the backward movement. 
When the cue “STOP” was presented, the participants were instructed to refrain from 
moving. Reaction times were defined as the time between movement cue (the arrow) 
onset and the release of the sensor box. Participants were motivated to perform the 
complete movement as fast and as accurately as possible. By including the backwards 
movement, the direction of the movement was made unpredictable. 
The participants received either a painful ES or a VT stimulus during movement 
execution in 1 out of 3 trials, depending on the color of the first cue. When the participants 
did not have to perform a movement, they never received any additional stimulation. The 
VT was triggered as soon as the participants lifted their finger from the light-sensitive 
sensorbox. To make sure the participants executed the movement correctly and in the 
correct direction, the participants were monitored by the experimenters. When 
participants had executed the movement, a timeline counting down 12 seconds was shown 
on the screen. In this timeframe, participants were instructed to keep breathing and to 
relax their muscles and had the time to position their fingertip back on the sensor-box and 
prepare for the next trial 22,23. The next trial started after an inter-trial interval of 500ms 
(see figure 1 for an overview). After this practice block, the experimental blocks started. 
The experimental blocks were exactly the same as the practice blocks, except for the 
number of trials. The experiment was divided into 2 blocks of 120 trials, with a seated 
rest of 90 seconds in-between blocks.  
 




2.5 Self-report instruments 
 
After obtaining informed consent, all participants were asked to fill out a general 
questionnaire in which the participants’ sociodemographic variables (name, date of birth, 
gender, civil status, parenthood, education, and profession), general health (pregnancy, 
medical and psychological health problems, medical procedures, treatments and therapy, 
and pain complaints). Participants with LBP were asked to fill out an additional 
questionnaire to register LBP relate information (e.g. the type, intensity, duration, 
localization, of the LBP, current and past treatments). In case the latter questionnaire 
indicated potential red flags for LBP of neurogenic origin a clinical examination was 
performed by a PT to rule out this was the case. Additionally, all participants were asked 
to complete Dutch versions of several validated questionnaires to assess theoretical 
antecedents of attention, severity of the problems, and psychological distress. 
2.5.1 Hospital Anxiety and Depression Scale (HADS) is developed to identify 
anxiety disorders and depression among patients with a general medical condition28. The 
HADS is a 14-item scale in which the participants have to report on a 4-point Likert scale 
the degree to which they have experienced anxious and or depressive feelings over the 
last week. The scale is divided into two subscales: 7 items for anxiety and also 7 for 
depression. Higher scores indicate greater levels of depression and anxiety, with scores 
between 8 and 10 considered as mild, 11 and 14 as moderate and between 15 and 21 as 
severe, for each subscale. The HADS has been shown to be a reliable and valid 
questionnaire in both general29,30 and chronic pain populations 31,32. 
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2.5.2 Pain Catastrophizing Scale (PCS) is a 13-item scale in which the 
participants are asked to reflect on previous painful experiences and to indicate their 
thoughts and feelings when experiencing pain33. Responses are given on a 5-point Likert 
scale ranging from 0 (not at all) to 4 (all the time). Larger scores represent larger 
catastrophizing behavior levels. Scores are clinically relevant when ≥30. Larger scores 
represent larger catastrophizing behavior levels. The PCS consists of three subscales: 
magnification, rumination, and helplessness. The Dutch version of the PCS has been 
shown to be valid and reliable both in healthy and chronic pain patients34. 
2.5.3 Pain Vigilance and Awareness Questionnaire (PVAQ) is a scale that 
consists of 16 items in which participants are asked to report on their vigilance for pain 
sensations on a Likert scale from 1 (“never”) to 5 (“always”)35. The PVAQ consists of 
two subscales, namely attention to pain and attention to changes in pain. High scores 
reflect increased levels of hypervigilance to pain sensations. The Dutch version of the 
PVAQ has been shown to be valid and reliable in both healthy populations and chronic 
pain patients 36,37. 
2.5.4 The Roland Morris Disability Questionnaire (RMDQ) was used to assess 
how daily physical activities and functioning are affected by LBP38. Participants are asked 
to answer 24 ‘yes-no’ questions on whether they experienced a specific situation 
regarding their low back pain that day. The total score ranges from 0 (no disability) to 24 
(severe disability) with higher scores indicating higher degrees of LBP related disability. 
The Dutch version of the RMDQ is shown to be valid and reliable to assess dysfunction 
in chronic low back pain39. 
2.5.5 The Tampa Scale of Kinesiophobia (TSK) a 17-item questionnaire that 
measures the fear of movement and (re)injury40. Items are answered on a 4-point Likert 
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scale ranging from 1 (“strongly disagree”) to 4 (“strongly agree”). A high value on this 
scale indicates a high degree of kinesiophobia, with a cutoff score of 37. The TSK has 
shown to be valid and sufficiently reliable41,42. 
2.5.6 Other self-reports. Immediately after the experiment, participants were 
asked to rate several items on a Likert scale from 0 to 10: expectations of pain (‘to what 
degree did you expect a white/pink/blue ball/rest trial to be followed by an unpleasant 
stimulus?’), fear of pain (‘to what degree did you fear that a white/pink/blue ball/ rest trial 
would be followed by an unpleasant stimulus?’) during the experiment, and 
unpleasantness (‘how unpleasant do you rate the electrocutaneous stimulus?’) and 
painfulness (‘how painful do you rate the electrocutaneous stimulus?’) of the ES (only in 
the pain session). Additionally, all participants were asked to indicate the amount of back 
pain they experienced at the day of testing on a VAS scale from 0 to 10. 
 
2.6 Data processing and analyses 
 
 2.6.1 Self-reports. Only participants’ the scores on theoretically relevant self-
reports and questionnaires (i.e. the PVAQ, PCS, and TSK) were compared between 
groups by conducting repeated-measures ANOVA’s and/or t-tests where applicable. 
Additionally, the total scores on the PCS, PVAQ, TSK, fear and expectancy ratings were 
correlated with the participants’ SEP amplitudes and RTs.  
2.6.2 EEG. Channels were re-referenced off-line to the average of all electrodes. 
EEG-signals were filtered with a low cutoff of 1 Hz and a high cutoff of 30 Hz. Next, an 
automatic artefact rejection was applied to the segments that ranged from -200 to 500 ms 
around the onset of the tactile stimulus. Through artefact rejection, all eye movements 
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that occurred right before and during tactile stimulus presentation were also removed (7.0 
% no threat trials and 7.0 % of the neutral trials for the controls, 8.4% and 8.8% for the 
RLBP, and 5.9% and 6.9% for the CLBP group correspondingly). Finally, baseline 
corrections were applied, and the average was calculated for each condition (trials with 
the threat of receiving the painful ES and trials without the threat of pain). A collapsed 
localizer was created by averaging the waveforms of all participants and all conditions43. 
Based on previous studies9,10,44 and visual inspection, clear peaks were detected at 
23 ms (positive), 30 ms (negative), 40 ms (positive), 96 ms (negative), and 172 ms 
(positive) (see figure 2). The presence of these peaks was confirmed by calculating the 
global field power across all participants and conditions. All peaks had a central 
topography centered around the Cz electrode. Mean area amplitudes were therefore 
exported from electrodes FC1, FC2 and CZ for the P23, N30, P40 and N96, and from 
electrodes FC1, FC2, Cz, CP1 and CP2 for the N172 component. This area information 
was extracted from an interval between 22 and 28 ms (P23), 26 and 34 ms (N30), 35 and 
45 ms (P40), 71 and 121 ms (N96), and an interval between 132 and 212 ms (P172). Mean 
area amplitudes were used because these are known to provide an unbiased measure of 
amplitude45. Comparisons between the participant groups (3 levels) and the two 
conditions (2 levels: trials with the threat of receiving the painful ES and trials without 
the threat of pain) were made by means of a 3 x 2 repeated-measures ANOVA, with 
condition as within-subjects factor and group as between-subjects factor, and additional 
t-tests where applicable.  
 




2.6.3 Reaction times (RT). Since we did not have any predictions about 
movement direction, the data from both directions were combined. All outliers were 
removed from the dataset (1.90%). This was done by eliminating all RTs lower than 100 
ms and larger than 2000 ms. Next, all RTs that were faster or slower than 3 times the 
standard deviation were also removed. RT data will be analyzed by conducting a 3x2 






One participant fainted during the pain session and was excluded from the 
analyses. Additionally, two participants dropped out after the no-pain session. Moreover, 
due to technical problems the EEG data of 16 participants was not recorded properly.  
Finally, 3 RLBP participants reported to experience a pain episode during the sessions 
and were excluded. In total, the data of 88 (34 control, 28 CLBP and 26 RLBP) 
individuals were included in the analysis (see table 1 for demographics). 
The RLBP individuals rated on a VAS scale from 0 to 10 their average pain 
intensity a 5.15 (SD = 1.75) out of 10, and their maximum pain intensity a 6.70 (SD = 
1.75) out of 10. The duration of the pain free periods ranged across participants between 
1 day and several weeks (up to 6 weeks). The participants’ last pain flare ranged between 
1 day to 9 months before the testing day. On average, the participants rated the intensity 
of their last pain flare a 4.97 (SD = 2.03) on a VAS scale from 0 to 10. The maximum 
pain intensity they felt during their last pain flare was rated 5.71 (SD = 2.32). The duration 
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of the last pain flare ranged between 3 hours and 14 days. Twelve participants have sought 
non-pharmacological treatment and 13 participants have used pharmacological treatment. 
Seven participants have used other types of treatment. Note that participants have 
combined several types of treatment.  
On a VAS scale from 0 to 10, the CLBP individuals on rated their pain intensity 
on average (not specifically on the testing day) 4.23 (SD = 1.47) and the maximum 
intensity 7.04 (SD = 1.78). Seventeen participants have sought non-pharmacological 
treatment and 15 participants have used pharmacological treatment. Eight participants 
have used alternative treatments.  
 




Table 1 shows the average scores on the questionnaires and other ratings. For the 
PCS, PVAQ, and TSK, there were no significant differences between the three groups 
(p’s >.05). Moreover, the groups did not differ significantly in the ratings on the 
painfulness and unpleasantness of the ES, pain expectancies, pain-related fear and low 
back pain ratings (all p’s >.05). 
 There were no differences between the groups on their total HADS score (all p’s 
>.05) or their scores on the depression subscale (all p’s>.05). However, on the anxiety 
subscale, there was a significant difference between the healthy and the RLBP group 
(t(43.479)=-5.24, p<.001, d = 0.68), and a significant difference between the healthy 
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group and the CLBP group (t(53.27)=-3.20, p=.002, d=.41). There was no difference 




[table 2 about here] 
 
3.3.1 P23. There were no significant main effects (condition: F(1,85)=.05, p=.820, 
d=.02, group: F(2,85)=.30, p=.740, d=.06), and no significant interaction between group 
and condition (F(2,85)=2.53, p=.085, d=.17).  
3.3.2 N30. There was no significant main effect of condition, F(1,85)=1.65, 
p=.202, d=.14, nor a significant main effect of group, F(2,85)=1.91, p=.154, d=.15. Also, 
no significant interaction effect was found (F(2,85)=2.62, p=.079, d=.17). 
3.3.3 P40. There were no significant main effects (condition: F(1,85)=.36, p=.550, 
d=0.06, group: F(2,85)=2.79, p=.067, d=.18), and no significant interaction between 
group and condition (F(2,85)=.52, p=.597, d=.08). 
3.3.4 N96. There was a significant main effect of condition, F(1,85)=11.59, 
p=.001, d=0.36, with a stronger negative waveform in threat trials than in neutral trials. 
No significant main effect of group F(2,85)=.08, p=.925, d=.03, nor a significant 
interaction between group and condition F(2,85)=.06, p=.943, d=.03, was found. 
3.3.5 P172. A significant main effect of condition was found, F(1,85)=9.75, 
p<.005, d=.33, with a stronger positive waveform in threat trials compared to neutral 
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trials. There was no significant main effect of group (F(2,85)=3.05, p=.053, d= .19) and 
no significant interaction between group and condition (F(2,85)=.29, p=.750, d=.06)1. 
 
3.4 Movement latency 
 
 The reaction time data of three participants were not registered correctly. 
Therefore, the data of these participants were not included in the analyses. The results 
showed that a significant main effect of condition (F(1,81)=42.74, p<.001, d=.70), with 
faster reaction times in threat trials (M=454.53, SD=65.14) compared to neutral trials 
(M=467.93, SD=65.36). There was no significant main effect of group (F(1,81)=0.78, 
p=.461, d=.09). There was also no significant interaction effect (F(2,81)=.28, p=.755, 
d=.06). 
 
3.5 Correlations  
 
The participants’ scores on the PVAQ, PCS, TSK, and their fear and expectancy 
ratings on the pain and no pain trials were correlated to the amplitudes of the different 





1 To check whether order of the session had an influence on the results, separate analyses 
were conducted which included session order as a factor. The effect of order never 
reached significance (always p>0.1) and was therefore excluded from the analyses 




The current study evaluated the role of hypervigilance in long term low back pain 
problems. SEPs were assessed to examine attentional processing of somatosensory 
stimuli at the lower back when preparing arm movements with or without threat of pain 
on the back. Individuals with CLBP, RLBP, and no LBP were compared. Results showed 
a significant effect of condition on the amplitude of the N96 SEP, indicating that, as 
expected, the participants attended more towards the stimuli on the back in threat trials 
than in neutral trials. However, the P172 SEP was larger when anticipating a threatening 
movement compared to a safe movement, but there was no difference between groups. 
Additionally, no significant associations between somatosensory attending to the back 
and theorized antecedents of hypervigilance were found. 
 The results showed larger N96 amplitudes in the threat trials compared to the 
neutral trials. This effect seems reminiscent to what was previously found in a study by 
Clauwaert and colleagues10. Similar to the current study, we measured SEPs to task-
irrelevant tactile stimuli on the lower back while healthy individuals prepared pain-
conditioned and neutral arm movements and found that the N95 component was larger 
when preparing the pain-conditioned movement, indicating increased somatosensory 
attending. The current study replicates these findings by showing an increased N96 for 
somatosensory input at the lower back when preparing a back-threatening movement. 
Contrarily to our hypothesis, the N96 effect did not differ between the CLBP, RLBP, and 
control groups. This seems to suggest that, in line with the study by Peters and 
colleagues8, persons with LBP problems were not hypervigilant for bodily sensations in 
the back. Note that also in persons with fibromyalgia, no behavioral evidence has been 
found for somatosensory hypervigilance46,47. However, such conclusion might still be 
21 
 
premature, and a number of issues should be considered. First, we examined how the 
threat of brief phasic electrocutaneous stimuli affected somatosensory attending to the 
back. It is possible that such effect is not representative for the attentional processes 
involved in naturally occurring back pain. However, it should be noted that also in the 
neutral condition (perhaps better reflecting the natural situation), no differences were 
found between groups. Nevertheless, it might be worthwhile for future studies to consider 
using tonic pain inductions. Second, it could well be that the threat of experimentally 
induced pain was not different between the groups, and therefore affected attending to the 
back to the same extent. The fact that the ratings of the ES intensity, expectations and fear 
did not differ between the different groups, seems to support this explanation. Third, the 
CLBP and RLBP groups were recruited from the general population rather than 
specialized clinical settings alone, which might have resulted in a more heterogeneous 
sample. While only participants who met the inclusion criteria for CLBP and RLBP were 
selected, the questionnaire scores suggest that these were relatively well functioning 
samples. For example, the average scores on the RMDQ were only 4.54 and 5.89 out of 
a maximum score of 24 for the CLBP and the RLBP groups correspondingly. 
Furthermore, the scores on the PCS and TSK scales are lower than those achieved in other 
studies on CLBP individuals 34,41,48, and did not significantly differ from the scores of the 
control group. The samples achieved in the current study may therefore not be 
representative of LBP patients who are more severely disabled.  
Interestingly, there was a significant effect of condition on the P172 component, 
which was larger in the threat condition compared to the safe condition. This component 
might correspond with the P166 component found in the study by Clauwaert et al.10, and 
which has been suggested to reflect a state of arousal during threat trials, resulting in 
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increased somatosensory responsiveness. Note that we also identified a number of earlier 
components (0-50 ms after tactile stimulus onset), which were not affected by condition 
or group. We had no hypotheses about these early SEPs, which have been suggested to 
originate from activity in the primary somatosensory cortex (SI)49. Interestingly, it has 
been suggested that early onset SEPs may reflect the suppression of sensory information 
that usually occurs when executing and even preparing a movement (i.e. sensory 
suppression50). It has been hypothesized that CLBP might negatively affect sensory 
suppression51, but the current study did not find indications for this.  
An interesting observation in the present study was that participants initiated the 
movement faster when they expected it to be combined with a painful stimulus on the 
back. Based on literature one would rather expect participants to be more hesitant when 
initiating a movement associated with pain 52,53. Possibly, this counter-intuitive finding 
could be explained by the fact the participants wanted to end the pain as soon as possible 
(“let’s get it over with”)54. Alternatively, the fearful anticipation of a painful stimulus 
may have activated a defensive response priming the motor system for escape from the 
threatening situation55,56,57 even though escaping from the threat was actually not possible 
for participants. Interestingly, the response latencies did not differ between the groups.  
The SEP amplitudes did not correlate with the self-reported fear and expectation 
of pain during the experiment nor with the fear and vigilance for pain, or the pain related 
catastrophizing behaviors. Since the expectancy or fear of pain is known to motivate 
people to scan their body for threats, these results are quite unexpected. It is possible, 
however, that the measures used in this study (both self-reports and/or ERP data) are not 




To conclude, the current study confirmed that individuals preparing a movement 
attended more towards somatosensory stimuli at the lower back when anticipating back 
pain during the movement, as measured by the N96 SEP. However, no differences were 
found for this component between participants suffering from CLBP or RLBP, or the 
healthy controls. Additionally, the present study was not able to find associations between 
somatosensory attention and pain-related attending and theorized antecedents such as 






The authors wish to thank Pascal Mestdagh and Tanneke Palmans from Ghent University 






All authors conceived of the present idea and paradigm. A.C. programmed the 
experiment. A.C. and S.S. conducted the study. A.C. processed all the data. A.C. wrote 





[1] Crombez, G., Eccleston, C., Van Damme, S., Vlaeyen, J.W., & Karoly, P. (2012). 
Fear-avoidance model of chronic pain: the next generation. Clin J Pain, 28(6), 
475-83. doi: 101097/AJP0b013e3182385392. 
[2] Leeuw, M., Goossens, M.E., Linton, S.J., Crombez, G., Boersma, K., & Vlaeyen, J.W. 
(2007). The fear-avoidance model of musculoskeletal pain: current state of 
scientific evidence. J Behav Med, 30(1), 77-94. 
[3] Todd, J., Van Ryckeghem, D., Sharpe, L., & Crombez G. (2018). Attentional bias to 
pain-related information: a meta-analysis of dot-probe studies. Health Psychol 
Rev, 12, 1-18. doi: 101080/1743719920181521729. 
[4] Crombez, G., Van Ryckeghem, D.M., Eccleston, C., & Van Damme, S. (2013). 
Attentional bias to pain-related information: a meta-analysis. Pain, 154(4), 497-
510. doi: 101016/jpain201211013. 
[5] Crombez, G., Van Damme, S., Eccleston, C. (2005). Hypervigilance to pain: An 
experimental and clinical analysis. Pain, 116(1-2),4-7. 
[6] Durnez, W., & Van Damme, S. (2015). Trying to fix a painful problem: the impact of 
pain control attempts on the attentional prioritization of a threatened body 
location. J Pain, 16(2), 135-143. 
[7] Vanden Bulcke, C., Van Damme, S., Durnez, W., & Crombez, G. (2013). The 
anticipation of pain at a specific location of the body prioritizes tactile stimuli at 
that location. Pain, 154(8), 1464-8. doi: 101016/jpain201305009. 
27 
 
[8] Peters, M.L., Vlaeyen, J.W.S., & Kunnen, A.M.W. (2002). Is pain-related fear a 
predictor of somatosensory hypervigilance in chronic low back pain patients?  
Behav Res Ther, 40(1), 85-103. 
[9] Clauwaert, A., Torta, D.M., Danneels, L., & Van Damme S. (2018). Attentional 
modulation of somatosensory processing during the anticipation of movements 
accompanying pain: an event-related potential study. Journal of Pain, 19(2), 219-
227. 
[10] Clauwaert, A., Cracco, E., Schouppe, S., Van Oosterwijck, J., Danneels, L. & Van 
Damme (2019). Somatosensory attending to the lower back is associated with 
response speed of movements signaling back pain. Brain Res, 1723(146383). doi: 
10.1016/j.brainres.2019.146383 
 [11] Airaksinen, O., Brox, J.I., Cedraschi, C., Hildebrandt, J., Klaber-Moffett, J., Kovacs, 
F., Mannion, A.F., Reis, S., Staal, J.B., Ursin, H., & Zanoli, G. (2006). COST B13 
Working Group on Guidelines for Chronic Low Back Pain. Chapter 4 European 
guidelines for the management of chronic nonspecific low back pain. Eur Spine 
J. 15 Suppl 2, S192-300. 
[12] de Vet, H.C., Heymans, H.W., Dunn, K.M., Pope, D.P., van der Beek, A.J., 
Macfarlane, G.J., Bouter , L.M., & Croft, P.R. (2002). Episodes of low back pain: 
a proposal for uniform definitions to be used in research. Spine,1(27), 2409-16.  
[13] D'Hooge, R., Cagnie, B., Crombez, G., Vanderstraeten, G., Dolphens, M., & 
Danneels, L. (2012). Increased intramuscular fatty infiltration without differences 
in lumbar muscle cross-sectional area during remission of unilateral recurrent low 
back pain. Man Ther, 17(6), 584-588. 
28 
 
[14] Kamper, S.J., Maher, C.G., Herbert, R.D., Hancock, M.J., Hush, J.M., & Smeets, 
R.J. (2010). How little pain and disability do patients with low back pain have to 
experience to feel that they have recovered? Eur Spine J, 19(9), 1495-1501. 
[15] Stanton, T.R., Latimer, J., Maher, C.G., & Hancock, M.J. (2010). How do we define 
the condition 'recurrent low back pain'? A systematic review. Eur Spine J, 19(4), 
533-539. 
[16] Goubert, D., Danneels, L., Graven-Nielsen, T., Descheemaeker, F., & Meeus, M. 
(2017). Differences in Pain Processing Between Patients with Chronic Low Back 
Pain, Recurrent Low Back Pain, and Fibromyalgia. Pain Physician,20(4), 307-
318. 
[17] Goubert, D., De Pauw, R., Meeus, M., Willems, T., Cagnie, B., Schouppe, S.,  Van 
Oosterwijck, J., Dhondt, E., & Danneels, L. (2017). Lumbar muscle structure and 
function in chronic versus recurrent low back pain: a cross-sectional study. Spine 
J, 17(9), 1285-1296. 
[18] Notebaert, L., Crombez, G., Van Damme, S., De Houwer, J, & Theeuwes, J. (2010). 
Looking out for danger: An attentional bias towards spatially predictable 
threatening stimuli. Behav Res and Ther, 48(11), 1150-1154 doi: 
101016/jbrat201007013. 
[19] Juravle, G., & Spence, C. (2011). Juggling reveals a decisional component to tactile 
suppression. Exp Brain Res, 213(1), 87-97. doi: 101007/s00221-011-2780-2. 
[20] Van Hulle, L., Juravle, G., Spence, C., Crombez, G., & Van Damme, S. (2013). 
Attention modulates sensory suppression during back movements. Conscious 
Cogn, 22(2), 420-9. doi: 101016/jconcog201301011. 
29 
 
[21] Stevens, M., Lammertyn, J., Verbruggen, F., & Vandierendonck, A. (2006) Tscope: 
A C library for programming cognitive experiments on the MS windows platform. 
Behav Res Methods, 38, 280–286. doi: 103758/BF03192779. 
[22] Hedayati, R., Kahrizi, S., Parnianpour, M., Bahrami, F., & Kazemnejad, A. (2010). 
The Study of the Variability of Anticipatory Postural Adjustments in Recurrent 
Non-Specific LBP Patients. International Scholarly and Scientific Research 
Innovation, 4(9). 
[23] Jacobs, J.V., Henry, S.M., & Nagle, K.J. (2009). People with chronic low back pain 
exhibit decreased variability in the timing of their anticipatory postural 
adjustments. Behav Neurosci, 123(2), 455-8. doi: 101037/a0014479. 
[24] Jacobs, J.V., Henry, S.M., & Nagle, K.J. (2010). Low back pain associates with 
altered activity of the cerebral cortex prior to arm movements that require postural 
adjustment. Clin Neurophysiol, 121(3), 431-40. doi: 101016/jclinph200911076. 
[25] Hodges, P.W., & Richardson, C.A. (1997) Feedforward contraction of transversus 
abdominis is not influenced by the direction of arm movement. Experimental 
brain research, 114(2),362-370. https://doiorg/101007/PL00005644. 
[26] Macdonald, D., Moseley, G.L., & Hodges, P.W. (2009). Why do some patients keep 
hurting their back? Evidence of ongoing back muscle dysfunction during 
remission from recurrent back pain. Pain, 142(3), 183-8. doi: 
101016/jpain200812002. 
[27] Field, A.P., & Storksen-Coulson, H. (2007). The interaction of pathways to fear in 
childhood anxiety: a preliminary study. Behav Res Ther,45(12), 3051-9. 
[28] Zigmond, A.S., & Snaith, R.P. (1983). The hospital anxiety and depression scale. 
Acta Psychiatr Scand, 67(6), 361-70. 
30 
 
[29] Bjelland, I., Dahl, A.A., Haug, T.T., & Neckelmann, D. (2002). The validity of the 
Hospital Anxiety and Depression Scale, An updated literature review. J 
Psychosom Res, 52(2), 69-77. 
[30] Julian, L.J. (2011). Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck 
Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety 
(HADS-A) Arthritis Care Res (Hoboken) 63, Suppl 11, S467-
472101002/acr20561. 
[31] Lynch, J., Moore, M., Moss-Morris, R., & Kendrick, T. (2011). Are patient beliefs 
important in determining adherence to treatment and outcome for depression? 
Development of the beliefs about depression questionnaire. J Affect Disord, 
133(1-2), 29-41. doi: 10.1016/j.jad.2011.03.019. 
[32] Turk, D.C., Dworkin, R.H., Trudeau, J.J., Benson, C., Biondi, D.M., Katz, N.P., & 
Kim, M. (2015). Validation of the Hospital Anxiety and Depression Scale in 
Patients with Acute Low Back Pain. J Pain, 16,1012-1021 
[33] Sullivan, M.J.L., Bishop, S.R., & Pivik, J. (1995). The Pain Catastrophizing Scale: 
Development and validation. Psychological Assessment, 7(4), 524-532. 
http://dxdoiorg/101037/1040-359074524. 
[34] Van Damme, S., Crombez, G., Bijttebier, P., Goubert, L., & Van Houdenhove, B. 
(2002). A confirmatory factor analysis of the Pain Catastrophizing Scale: invariant 
factor structure across clinical and non-clinical populations. Pain, 96, 319-324. 
[35] McCracken, L.M.  (1997). “Attention” to pain in persons with chronic pain: A 




[36] Roelofs, J., Peters, M.L., McCracken, L., & Vlaeyen, J.W. (2003). The pain vigilance 
and awareness questionnaire (PVAQ): further psychometric evaluation in 
fibromyalgia and other chronic pain syndromes. Pain, 101(3), 299-306.  
[37] Roelofs, J., Peters, M. L, Muris, P., & Vlaeyen, J.W. (2002). Dutch version of the 
Pain Vigilance and Awareness Questionnaire: validity and reliability in a pain-
free population. Behav Res Ther, 40(9), 1081-90.  
[38] Roland, M., & Morris, R. (1983). A study of the natural history of back pain Part I: 
development of a reliable and sensitive measure of disability in low-back pain.  
Spine, 8(2), 141-4. 
[39] Gommans, I.H.B., Koes, B.W., & van Tulder, M.W. (1997). Validiteit en 
responsiviteit Nederlandstalige Roland Disability Questionnaire Vragenlijst naar 
functionele status bij patiënten met lage rugpijn. Nederlands Tijdschrift voor 
Fysiotherapie, 107, 28 – 33. 
[40] Vlaeyen, J.W., Kole-Snijders, A.M., Boeren, R.G., & van Eek, H. (1995). Fear of 
movement/(re)injury in chronic low back pain and its relation to behavioral 
performance. Pain, 62(3), 363-72. 
[41] Goubert, L., Crombez, G., Van Damme, S., Vlaeyen, J.W., Bijttebier, P., & Roelofs, 
J. (2004). Confirmatory factor analysis of the Tampa Scale for Kinesiophobia: 
invariant two-factor model across low back pain patients and fibromyalgia 
patients. Clin J Pain, 20(2), 103-10. 
[42] Roelofs, J., Goubert, L., Peters, M. L, Vlaeyen, J.W., & Crombez, G. (2004). The 
Tampa Scale for Kinesiophobia: further examination of psychometric properties 




[43] Luck, S.J., & Gaspelin, N. (2017). How to get statistically significant effects in any 
ERP experiment (and why you shouldn’t). Psychophysiology, 54,146-157. 
doi:101111/psyp12639. 
[44] Lenoir, C., Huang, G., Vandermeeren, Y., Hatem, S.M., & Mouraux, A. (2017). 
Human primary somatosensory cortex is differentially involved in vibrotaction 
and nociception. J Neurophysiol, 118(1), 317-330. doi: 101152/jn006152016. 
[45] Luck, S.J. (2014) An introduction to the event-related potential technique (2nd ed) 
Cambridge, MA: MIT Press. 
[46] Tiemann, L., Schulz, E., Winkelmann, A., Ronel, J., Henningsen, P., & Ploner, M. 
(2012). Behavioral and Neuronal Investigations of Hypervigilance in Patients 
with Fibromyalgia Syndrome. Plos One, 7(4), e35068 doi: 
101371/journalpone0035068. 
[47] Van Damme, S., Van Hulle, L., Spence, C., Devulder, J., Brusselmans, G., & 
Crombez, G. (2015). Hypervigilance for innocuous tactile stimuli in patients with 
fibromyalgia: an experimental approach. Eur J Pain, 19(5), 706-714. 
[48] Van Damme, S., Crombez, G., Vlaeyen, J.W.S., Goubert, L., Van den Broeck, A., 
& Van Houdenhove B. (2000). De Pain Catastrohizing Scale: Psychometrische 
karakteristieken en normering. Gedragstherapie, 33(3), 211-222. 
 [49] Bradley, C., Joyce, N., & Garcia-Larrea, L. (2016). Adaptation in human 
somatosensory cortex as a model of sensory memory construction: a study using 




[50] Juravle, G., Binsted, G., & Spence, C. (2017). Tactile suppression in goal-directed 
movement. Psychon Bull Rev, 24(4), 1060-1076 doi: 103758/s13423-016-1203-
6. 
[51] Van Damme, S., Van Hulle, L., Danneels, L., Spence, C., Crombez, G. (2014). The 
effect of chronic low back pain on tactile suppression during back movements. 
Human Movement Science, 37: 87-100. 
[52] Meulders, A., & Vlaeyen, J.W. (2013). The acquisition and generalization of cued 
and contextual pain-related fear: an experimental study using a voluntary 
movement paradigm. Pain, 154(2), 272-82. doi: 101016/jpain201210025. 
[53] Meulders, A., Vansteenwegen, D., & Vlaeyen, J.W. (2011). The acquisition of fear 
of movement-related pain and associative learning: a novel pain-relevant human 
fear conditioning paradigm. Pain, 152(11), 2460-9. doi: 101016/jpain201105015. 
[54] Karos, K., Meulders, A., Gatzounis, R., Seelen, H.A.M., Geers, R.P.G., & Vlaeyen, 
J.W.S. (2017). Fear of pain changes movement: Motor behaviour following the 
acquisition of pain-related fear. Eur J Pain, 21(8),1432-1442. 
[55] Hagenaars, M.A., Oitzl, M., & Roelofs, K. (2015). Updating freeze: Aligning anima 
land human research. Neurosci Biobehav Rev, 47, 165-76. doi: 
101016/jneubiorev201407021. 
 [56] Krypotos, A.M., Effting, M., Kindt, M., & Beckers, T. (2015). Avoidance learning: 
a review of theoretical models and recent developments. Frontiers in Behavioral 
Neuroscience, 9, 1-16. doi: 103389/fnbeh201500189. 
[57] Perini, I., Bergstrand, S., & Morrison, I. (2013). Where pain meets action in the 






Figure 1. Overview of the trials. A fixation cross was presented at the start of the trial (0 
ms). After 500 ms, the fixation cross was replaced by cue 1, indicating whether the 
participant could expect a painful ES or neutral VT during movement execution. Between 
2500-3000 ms after the onset of the trial, participants received a VT (200 ms) to evoke 
an SEP. Next, at 3500 ms after onset of the trial, cue 1 was replaced by the movement 
cue. A movement trial ended after 16500 ms. The next trial started after an ITI of 500 ms. 
 
Figure 2. Above: waveforms as presented at the Cz electrode for both conditions (red 
lines: threat condition, black lines: no threat condition) for the three different groups 
(healthy controls, recurrent low back pain group and chronic low back pain group) Below: 




Table 1. Demographics and questionnaire scores for the different participant groups. All 
scores represent means (M) and standard deviations (SD) unless otherwise specified. 
 















































Table 1. Demographics and questionnaire scores for the different participant groups. All scores 
represent means (M) and standard deviations (SD) unless otherwise specified 
  Controls RLBP CLBP 
    
N 34 26 28 
gender (N female) 17 15 15 
age in years  32 (6.71) 29 (6.64) 31 (7.13) 
righthandedness (N left dominant) 2 3 4 
selected stimulus intensity in mA  4.0 (2.12) 4.6 (2.30) 3.8 (2,77) 
education years  17.13 (2.93) 17.42 (2.12) 17 (2.63) 
    
back pain at day of testing  .05 (.22) .87 (1.13) 2.46 (1.94) 
    
painfullness electrocutaneous stimulus  4.29 (2.22) 4.49 (2.27) 4.94 (2.32) 
unpleasantness electrocutaneous stimulus 5.11 (2.42) 5.64 (1.93) 5.75 (2.62) 
rating pain expectancies after pain cue 4.47 (1.90) 5.43 (1.74) 4.9 (2.70) 
rating pain expectancies after no pain cue .14 (.42) .26 (1.12) .34 (.79) 
rating pain expectancies after rest cue .77 (1.13) .69 (1.52) 1.18 (2.31) 
fear for electrocutaneous stimulus after pain cue  3.95 (2.90) 5.06 (2.94) 4.29 (2.84)  
fear for electrocutaneous stimulus after no pain cue  .10 (.35) .08 (.31) .37 (.94) 
fear for electrocutaneous stimulus after rest cue  .58 (1.18) .44 (1.19) .99 (2.11) 
pain ratings during experiment  .68 (1.34) 2.74 (2.68) 4.80 (2.78 
    
HADS total score  6.06 (5.12) 8.08 (4.54) 9.86 (6.21) 
HADS depression subscale  2.05 (2.53) 3.00 (2.50) 3.25 (3.34) 
HADS anxiety subscale  4.00 (2.90) 5.08 (2.87) 6.61 (3.41)  
PVAQ total score  29.38 (12.02) 
33.23 
(11.05) 34 (12.76)  
PCS total score  11.35 (9.05) 12.69 (7.98) 14.64 (7.52)  
TSK total score  31.82 (8.67) 33.85 (7.69) 33.14 (8.86) 











Table 2. Mean amplitudes and standard deviations for each condition and group.  
 
      Controls RLBP CLBP 
P23 pain  1.32 (.97) 1.27 (1.05) 1.13 (1.13) 
 no pain  1.39 (.96) 1.07 (.97) 1.31 (1.01) 
      
N30 pain  1.50 (1.13) 1.06 (.91) 1.19 (1.39) 
 no pain  1.60 (1.15) .94 (.80) 1.44 (1.17) 
      
P40 pain  1.57 (1.38) .83 (1.08) 1.53 (1.72) 
 no pain  1.56 (1.46) .83 (.91) 1.67 (1.44) 
      
N96 pain  -5.71 (2.86) -6.04 (3.49) -5.98 (3.04) 
 no pain  -5.03 (2.78) -5.18 (3.21) -5.28 (3.25) 
      
P172 pain  3.34 (1.91) 3.67 (2.26) 4.50 (1.80) 
  no pain   2.95 (1.90) 3.69 (2.12) 4.30 (1.70) 
 
 
